← United States · All US Insider Profiles
US INSIDER PROFILE · NON-SCORING RESEARCH
Casdin Eli
10% Owner | Director
Identity: SEC reporting-owner CIK · Reporting-owner CIK: 0001534264
Purchase history
- Companies traded
- 2
- Purchases · 12M
- 7
- Purchases · 24M
- 12
- Average purchase
- $4.5M
- Median purchase
- $1.2M
- Gross purchase value
- $54.0M
Companies: GeneDx Holdings Corp. | STANDARD BIOTOOLS INC.
12 SEC accession(s) · 12 joint-owner event(s). Values are reported Form 4 transaction values in USD.
Qualifying purchase disclosures
| Published | Company | Ticker | Role | Reported value | SEC source |
|---|---|---|---|---|---|
| 2026-06-08 | GeneDx Holdings Corp. | WGS | Director | 10% Owner | $11.1M | Open filing |
| 2026-05-20 | GeneDx Holdings Corp. | WGS | Director | 10% Owner | $21.5M | Open filing |
| 2025-12-04 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $503.0K | Open filing |
| 2025-11-26 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $10.0M | Open filing |
| 2025-11-20 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $1.4M | Open filing |
| 2025-11-17 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $1.1M | Open filing |
| 2025-11-12 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $1.4M | Open filing |
| 2025-09-11 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $129.0K | Open filing |
| 2025-09-05 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $637.5K | Open filing |
| 2025-08-26 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $657.5K | Open filing |
| 2025-08-15 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $442.4K | Open filing |
| 2025-03-04 | STANDARD BIOTOOLS INC. | LAB | Director | 10% Owner | $5.2M | Open filing |
Post-purchase outcomes
Excess return = stock return − S&P 500 ETF (SPY adjusted close) return. Returns start on the first shared trading session on or after publication.
| Period | Completed events | Price coverage | Hit rate | Median excess return | Average excess return | Worst excess return |
|---|---|---|---|---|---|---|
| 5D | 2Small Sample | 16.7% (2/12) | 100.0% (2/2) | +13.3% | +13.3% | +10.3% |
| 20D | 2Small Sample | 16.7% (2/12) | 100.0% (2/2) | +28.3% | +28.3% | +25.6% |
| 60D | 2Small Sample | 16.7% (2/12) | 100.0% (2/2) | +66.1% | +66.1% | +63.6% |
| 120D | 0No Data | 0.0% (0/10) | — | — | — | — |
Research patterns
- First purchase in 12M
- 1/11
- Large purchase ≥ $100k
- 12/12
- Cluster buying · 15D
- 12/12
- Buying the dip
- 2/2
Routine / opportunistic: Not classifiable. These labels never affect the score or ranking.
Small samples remain visible but are not scored. This research enrichment never affects US-v1.1.